Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma
- 1 January 2021
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 23 (1) , 120-129
Abstract
No abstract availableKeywords
Funding Information
- Center for Translational Molecular Medicine (03O-102)
- Horizon 2020 (701143)
This publication has 21 references indexed in Scilit:
- Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myélome ExperienceJournal of Clinical Oncology, 2013
- A gene expression signature for high-risk multiple myelomaLeukemia, 2012
- Effect of Tissue Shipping on Plasma Cell Isolation, Viability, and RNA Integrity in the Context of a Centralized Good Laboratory Practice–Certified Tissue Banking FacilityCancer Epidemiology, Biomarkers & Prevention, 2008
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Multiple MyelomaNew England Journal of Medicine, 2004
- Incidence of multiple myeloma in Olmsted County, MinnesotaCancer, 2004
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- Robust Tests for the Equality of VariancesJournal of the American Statistical Association, 1974
- An analysis of variance test for normality (complete samples)Biometrika, 1965
- Sample Criteria for Testing Outlying ObservationsThe Annals of Mathematical Statistics, 1950